CareLit Fachartikel

Typ 2-diabetes lower costs of diabetes care with insulin glargine compared to insulin detemir in type 2 diabetes patients treated with a basal-bolus regimen

RA Bierwirth, T Kohlmann, KH Theobald, R Holle, W Landgraf · Diabetologie und Stoffwechsel · 2009 · Heft 05

Dokument
1165896
CareLit-ID
Jahr
2009
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Diabetologie und Stoffwechsel
Autor:innen
RA Bierwirth, T Kohlmann, KH Theobald, R Holle, W Landgraf
Ausgabe
Heft 05 / 2009
Seiten
–
Erschienen: 2009-05-19 00:00:00
ISSN
1861-9002
DOI
10.1055/s-0029-1222039

Zusammenfassung

Objective: Basal insulin analogs are well-established drugs in the treatment of diabetes. Besides clinical aspects the economic impact of such drugs on health care systems is very important. We examined and compared resource utilization and costs of diabetes care in type 2 diabetic (T2D) patients treated in a basal-bolus regimen with either glargine (GLA) or detemir (DET) as basal insulin. Methods: LIVE-COM* was a non-interventional, cross-sectional, retrospective study performed between April and September 2008 in 148[d1] [Sh2] randomly selected centers of primary care physicians in Germany. The study enroled 1…

Schlagworte

Blood Glucose Blood Germany Blood Glucose Self-Monitoring Physicians Diabetologie und Stoffwechsel